title: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.
authors.affiliation: Med. Dept. III, Klinikum Grosshadern, Munich University, FRG.
authors.forename: H H
authors.initials: HH
authors.lastname: Gerhartz
authors.forename: G
authors.initials: G
authors.lastname: Visani
authors.forename: A
authors.initials: A
authors.lastname: Delmer
authors.forename: H
authors.initials: H
authors.lastname: Zwierzina
authors.forename: M
authors.initials: M
authors.lastname: Ribeiro
authors.forename: A
authors.initials: A
authors.lastname: Jacobs
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: M
authors.initials: M
authors.lastname: Baumelou
authors.forename: D
authors.initials: D
authors.lastname: Fière
authors.forename: B
authors.initials: B
authors.lastname: Labar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003115:Colony-Stimulating Factors / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000628:therapy; D016032:Randomized Controlled Trials as Topic
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor